phosphatidylinositol 5-phosphate

Phosphatidylinositol 5-phosphate (PI5P) is a low-abundance phosphoinositide that acts as a second messenger in cellular signaling pathways. It is primarily regulated by the enzyme phosphatidylinositol-5-phosphate 4-kinase (PIP4K), which converts PI5P into PI(4,5)P2. Research indicates that PI5P plays a role in regulating gene expression, particularly in the context of hemoglobinopathies. Specifically, PI5P has been shown to stabilize the UHRF1 protein, which acts as a repressor of the HBG gene (gamma-globin). In experimental models, exogenous PI5P treatment increases fetal hemoglobin (HbF) expression by upregulating HBG transcripts and gamma-globin protein levels, while simultaneously downregulating its own regulatory kinases. This mechanism suggests PI5P or its metabolic pathway as a potential therapeutic target for sickle cell disease and beta-thalassemia.

Other names

1-phosphatidyl-1D-myo-inositol 5-phosphate